D. E. Shaw & Co., Inc. Scholar Rock Holding Corp Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 111,866 shares of SRRK stock, worth $869,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111,866
Previous 95,291
17.39%
Holding current value
$869,198
Previous $1.79 Million
10.89%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SRRK
# of Institutions
165Shares Held
73.6MCall Options Held
501KPut Options Held
26.3K-
Artal Group S.A. Luxembourg, N411.3MShares$87.5 Million10.78% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.21MShares$63.8 Million0.02% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$52.7 Million38.03% of portfolio
-
Redmile Group, LLC San Francisco, CA6.42MShares$49.9 Million4.49% of portfolio
-
Black Rock Inc. New York, NY5.01MShares$38.9 Million0.0% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $401M
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...